Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Current Liabilities -----

What is the latest Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is - based on Mar2024 Consolidated results.
Year Current Liabilities
Mar2024-
Mar2023-
Mar2022-
Mar2017-
Mar2016-

How is Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Current Liabilities % Change
Mar2024 -
0
Mar2023 -
0
Mar2022 -
0
Mar2017 -
0
Mar2016 - -

Compare Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹2,053.9 Cr 5.3% 29.8% 84.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,768.0 Cr 0.4% -1.2% 12.2% Stock Analytics
DIVIS LABORATORIES ₹178,468.0 Cr 2.6% 8.4% 48.5% Stock Analytics
CIPLA ₹121,326.0 Cr -0.1% 0.5% 1.7% Stock Analytics
DR REDDYS LABORATORIES ₹113,757.0 Cr 3.2% 11.8% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,345.0 Cr 3.4% 0.5% 12.8% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

5.3%

29.8%

84.3%

SENSEX

0.3%

0.7%

8.8%


You may also like the below Video Courses